CM Management’s Pfizer PFE Stock Holding History

CM Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$482K	Buy	+20,000	New	+$523K	0.31%	67
2025 Q4	–	Sell	-45,000	Closed	-$1.15M	–	70
2025 Q3	$1.15M	Hold	45,000	–	–	0.96%	40
2025 Q2	$1.09M	Buy	+45,000	New	+$1.05M	0.99%	36
2024 Q4	–	Sell	-60,000	Closed	-$1.74M	–	64
2024 Q3	$1.74M	Buy	60,000 +10,000	+20%	+$292K	1.39%	32
2024 Q2	$1.4M	Hold	50,000	–	–	1.28%	34
2024 Q1	$1.39M	Hold	50,000	–	–	1.17%	37
2023 Q4	$1.44M	Buy	+50,000	New	+$1.51M	1.16%	32
2021 Q3	–	Sell	-50,000	Closed	-$1.96M	–	94
2021 Q2	$1.96M	Hold	50,000	–	–	1.42%	19
2021 Q1	$1.81M	Buy	50,000 +40,000	+400%	+$1.42M	1.35%	19
2020 Q4	$368K	Buy	+10,000	New	+$367K	0.34%	66

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CM Management's PFE Position: Q2 2026 in Review

CM Management opened a new position in Pfizer (PFE) in Q2 2026: 20,000 shares worth $482K. The stake represents 0.31% of the portfolio and ranks #67 among its holdings. This is a return to the name: CM Management previously reported a position in PFE as recently as Q3 2025.

CM Management first reported a position in PFE in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.96M in Q2 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

CM Management held 20,000 shares of Pfizer worth $482K as of Q2 2026.
Pfizer was a new CM Management position in Q2 2026.
Pfizer made up 0.31% of CM Management's portfolio in Q2 2026, its #67 holding.
CM Management first reported a position in Pfizer in Q4 2020 and has held it in 10 quarters since.
CM Management's Pfizer position peaked at $1.96M in Q2 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.